STOCK TITAN

Isabella Financials

ISBA
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Isabella (ISBA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ISBA FY2025

Funding-cost pressure, not sheer balance-sheet growth, is the main earnings driver, and high leverage makes small shifts matter.

The FY2025 rebound looks higher quality than the FY2024 dip because net income rose to $18.9M and operating cash flow to $26.8M while interest expense was roughly flat year over year. At the same time, debt-to-equity eased from 8.9x to 8.5x as equity rebuilt, so the improvement was not bought by piling on more leverage.

With total assets at $2.2B but return on assets only 0.9% in FY2025, this business earns thin profits on a large base of assets. That is why returns to equity can still reach 8.2% even though asset-level profitability looks modest: leverage does the lifting.

This is also a low fixed-asset-intensity model: FY2025 capital spending was just $3.5M against free cash flow of $23.3M, so cash generation depends more on balance-sheet performance than on building physical assets. Because capex is small, the main constraint on capital returns is balance-sheet capacity, not plant spending.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 27 / 100
Financial Profile 27/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Isabella's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
50

Isabella's revenue grew 6.7% year-over-year to $96.0M, a solid pace of expansion. This earns a growth score of 50/100.

Leverage
0

Isabella has elevated debt relative to equity (D/E of 8.55), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Cash Flow
83

Isabella converts 24.3% of revenue into free cash flow ($23.3M). This strong cash generation earns a score of 83/100.

Returns
29

Isabella generates a 8.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 29/100. This is up from 6.6% the prior year.

Piotroski F-Score Neutral
6/9

Isabella passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.42x

For every $1 of reported earnings, Isabella generates $1.42 in operating cash flow ($26.8M OCF vs $18.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$96.0M
YoY+6.7%
5Y CAGR+8.4%
10Y CAGR+6.4%

Isabella generated $96.0M in revenue in fiscal year 2025. This represents an increase of 6.7% from the prior year.

EBITDA
N/A
Net Income
$18.9M
YoY+36.2%
5Y CAGR+11.7%
10Y CAGR+2.3%

Isabella reported $18.9M in net income in fiscal year 2025. This represents an increase of 36.2% from the prior year.

EPS (Diluted)
$2.56
YoY+37.6%
5Y CAGR+13.8%
10Y CAGR+3.0%

Isabella earned $2.56 per diluted share (EPS) in fiscal year 2025. This represents an increase of 37.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$23.3M
YoY+33.1%
5Y CAGR+2.6%
10Y CAGR+12.9%

Isabella generated $23.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 33.1% from the prior year.

Cash & Debt
$26.0M
YoY+6.1%
5Y CAGR-36.2%
10Y CAGR+1.9%

Isabella held $26.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.12
YoY+0.0%
5Y CAGR+0.7%
10Y CAGR+1.8%

Isabella paid $1.12 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
7M
YoY-1.4%
5Y CAGR-1.7%
10Y CAGR-0.6%

Isabella had 7M shares outstanding in fiscal year 2025. This represents a decrease of 1.4% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
19.7%
YoY+4.2pp
5Y CAGR+2.7pp
10Y CAGR-9.7pp

Isabella's net profit margin was 19.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.2 percentage points from the prior year.

Return on Equity
8.2%
YoY+1.6pp
5Y CAGR+3.2pp
10Y CAGR-0.1pp

Isabella's ROE was 8.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$4.7M
YoY+53.1%

Isabella spent $4.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 53.1% from the prior year.

Capital Expenditures
$3.5M
YoY+65.2%
5Y CAGR+18.0%
10Y CAGR-3.8%

Isabella invested $3.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 65.2% from the prior year.

ISBA Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $25.1M-0.6% $25.3M+1.6% $24.9M+7.1% $23.2M+2.7% $22.6M-2.3% $23.2M-0.7% $23.3M+5.7% $22.1M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $7.9M+5.3% $7.5M-1.3% $7.6M+1.8% $7.5M+1.5% $7.4M+0.6% $7.3M+1.2% $7.3M+4.0% $7.0M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $8.2M-3.5% $8.6M-1.9% $8.7M+7.5% $8.1M+0.1% $8.1M-5.9% $8.6M-2.7% $8.9M+3.7% $8.5M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $5.0M+6.4% $4.7M-10.5% $5.2M+4.2% $5.0M+27.4% $3.9M-1.2% $4.0M+21.8% $3.3M-5.7% $3.5M
EPS (Diluted) $0.68 N/A $0.71+4.4% $0.68+28.3% $0.53 N/A $0.44-4.3% $0.46

ISBA Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $2.3B+1.9% $2.2B-2.2% $2.3B+4.8% $2.2B+2.5% $2.1B+0.8% $2.1B-1.0% $2.1B+2.3% $2.1B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $50.1M+92.4% $26.0M-83.9% $161.3M+48.6% $108.6M+56.9% $69.2M+181.9% $24.5M-10.4% $27.4M+16.2% $23.6M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A $48.3M N/A N/A N/A $48.3M N/A N/A
Total Liabilities $2.0B+2.0% $2.0B-2.7% $2.0B+5.0% $1.9B+2.6% $1.9B+0.6% $1.9B-0.9% $1.9B+1.9% $1.9B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $234.0M+1.1% $231.4M+1.7% $227.4M+3.1% $220.5M+2.3% $215.6M+2.5% $210.3M-1.3% $213.0M+5.3% $202.2M
Retained Earnings $116.8M+2.6% $113.8M+2.4% $111.2M+3.0% $107.9M+2.9% $104.9M+1.9% $103.0M+1.9% $101.1M+1.3% $99.8M

ISBA Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $3.8M-67.2% $11.5M+319.6% $2.7M-65.2% $7.9M+70.0% $4.6M-34.8% $7.1M+100.5% $3.6M-35.7% $5.5M
Capital Expenditures $536K-39.0% $878K-13.7% $1.0M+69.5% $600K-39.0% $984K+90.7% $516K+42.9% $361K-12.2% $411K
Free Cash Flow $3.2M-69.6% $10.6M+515.5% $1.7M-76.3% $7.3M+99.3% $3.7M-44.6% $6.6M+107.1% $3.2M-37.6% $5.1M
Investing Cash Flow -$18.4M+79.2% -$88.7M-107.7% -$42.7M-236.1% -$12.7M-145.1% $28.2M+147.4% $11.4M+133.0% -$34.5M-614.5% -$4.8M
Financing Cash Flow $38.7M+166.6% -$58.1M-162.7% $92.7M+109.8% $44.2M+273.3% $11.8M+155.4% -$21.3M-161.3% $34.8M+1578.6% -$2.4M
Dividends Paid $2.1M+1.9% $2.0M-0.2% $2.0M-0.2% $2.0M-0.5% $2.0M-0.2% $2.0M+0.6% $2.0M+1.7% $2.0M
Share Buybacks $402K-72.3% $1.4M+138.1% $609K-59.5% $1.5M+31.4% $1.1M+74.3% $657K-35.4% $1.0M+53.6% $662K

ISBA Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 19.9%+1.3pp 18.6%-2.5pp 21.1%-0.6pp 21.6%+4.2pp 17.4%+0.2pp 17.3%+3.2pp 14.1%-1.7pp 15.8%
Return on Equity 2.1%+0.1pp 2.0%-0.3pp 2.3%+0.0pp 2.3%+0.5pp 1.8%-0.1pp 1.9%+0.4pp 1.5%-0.2pp 1.7%
Return on Assets 0.2%+0.0pp 0.2%-0.0pp 0.2%0.0pp 0.2%+0.0pp 0.2%0.0pp 0.2%+0.0pp 0.2%0.0pp 0.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 8.63+0.1 8.55-0.4 8.94+0.2 8.78+0.0 8.75-0.2 8.92+0.0 8.89-0.3 9.19
FCF Margin 12.9%-29.2pp 42.1%+35.2pp 7.0%-24.4pp 31.4%+15.2pp 16.2%-12.3pp 28.5%+14.9pp 13.7%-9.5pp 23.2%

Similar Companies

Frequently Asked Questions

Isabella (ISBA) reported $96.0M in total revenue for fiscal year 2025. This represents a 6.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Isabella (ISBA) revenue grew by 6.7% year-over-year, from $90.0M to $96.0M in fiscal year 2025.

Yes, Isabella (ISBA) reported a net income of $18.9M in fiscal year 2025, with a net profit margin of 19.7%.

Isabella (ISBA) reported diluted earnings per share of $2.56 for fiscal year 2025. This represents a 37.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Isabella (ISBA) had a net profit margin of 19.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Isabella (ISBA) paid $1.12 per share in dividends during fiscal year 2025.

Isabella (ISBA) has a return on equity of 8.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Isabella (ISBA) generated $23.3M in free cash flow during fiscal year 2025. This represents a 33.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Isabella (ISBA) generated $26.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Isabella (ISBA) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Isabella (ISBA) invested $3.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Isabella (ISBA) spent $4.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Isabella (ISBA) had 7M shares outstanding as of fiscal year 2025.

Isabella (ISBA) had a debt-to-equity ratio of 8.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Isabella (ISBA) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Isabella (ISBA) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Isabella (ISBA) has an earnings quality ratio of 1.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Isabella (ISBA) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top